EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells.

MLA

Choi, Yoo Jin, et al. “EpCAM Peptide-Primed Dendritic Cell Vaccination Confers Significant Anti-Tumor Immunity in Hepatocellular Carcinoma Cells.” PLoS ONE, vol. 13, no. 1, Jan. 2018, pp. 1–15. EBSCOhost, https://doi.org/10.1371/journal.pone.0190638.

APA

Choi, Y. J., Park, S.-J., Park, Y.-S., Park, H. S., Yang, K. M., & Heo, K. (2018). EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells. PLoS ONE, 13(1), 1–15. https://doi.org/10.1371/journal.pone.0190638

Chicago

Choi, Yoo Jin, Seong-Joon Park, You-Soo Park, Hee Sung Park, Kwang Mo Yang, and Kyu Heo. 2018. “EpCAM Peptide-Primed Dendritic Cell Vaccination Confers Significant Anti-Tumor Immunity in Hepatocellular Carcinoma Cells.” PLoS ONE 13 (1): 1–15. doi:10.1371/journal.pone.0190638.